共 224 条
[1]
Papadopoulos MC(2012)Aquaporin 4 and neuromyelitis optica Lancet Neurol 11 535-544
[2]
Verkman AS(2008)Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica Nat Clin Pract Neurol 4 202-214
[3]
Jarius S(2016)The immunology of neuromyelitis optica-current knowledge, clinical implications, controversies and future perspectives Int J Mol Sci 17 273-1114
[4]
Paul F(1999)The clinical course of neuromyelitis optica (Devic’s syndrome) Neurology 53 1107-200
[5]
Franciotta D(2018)Diagnosis and management of neuromyelitis optica spectrum disorders - an update Autoimmun Rev 17 195-361
[6]
Waters P(2010)Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice Brain 133 349-551
[7]
Zipp F(2014)Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG Acta Neuropathol 127 539-2591
[8]
Hohlfeld R(2010)Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury Brain 133 2578-2481
[9]
Vincent A(2008)Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 J Exp Med 205 2473-14786
[10]
Wildemann B(2016)Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4 Proc Natl Acad Sci U S A 113 14781-798